210 related articles for article (PubMed ID: 35011575)
1. The Cytoplasmic Dynein Associated Protein NDE1 Regulates Osteoclastogenesis by Modulating M-CSF and RANKL Signaling Pathways.
Das BK; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
Cells; 2021 Dec; 11(1):. PubMed ID: 35011575
[TBL] [Abstract][Full Text] [Related]
2. LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42.
Ye S; Fujiwara T; Zhou J; Varughese KI; Zhao H
Int J Biol Sci; 2016; 12(12):1488-1499. PubMed ID: 27994513
[TBL] [Abstract][Full Text] [Related]
3. Role of IGF-I signaling in regulating osteoclastogenesis.
Wang Y; Nishida S; Elalieh HZ; Long RK; Halloran BP; Bikle DD
J Bone Miner Res; 2006 Sep; 21(9):1350-8. PubMed ID: 16939393
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.
Ng PY; Cheng TS; Zhao H; Ye S; Sm Ang E; Khor EC; Feng HT; Xu J; Zheng MH; Pavlos NJ
J Bone Miner Res; 2013 Jan; 28(1):119-34. PubMed ID: 22887640
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Lineage Ablation of
Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
[TBL] [Abstract][Full Text] [Related]
6. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
[TBL] [Abstract][Full Text] [Related]
7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
8. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
10. Functional interplay between LIS1, NDE1 and NDEL1 in dynein-dependent organelle positioning.
Lam C; Vergnolle MA; Thorpe L; Woodman PG; Allan VJ
J Cell Sci; 2010 Jan; 123(Pt 2):202-12. PubMed ID: 20048338
[TBL] [Abstract][Full Text] [Related]
11. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
12. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
13. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1.
Ye S; Fowler TW; Pavlos NJ; Ng PY; Liang K; Feng Y; Zheng M; Kurten R; Manolagas SC; Zhao H
PLoS One; 2011; 6(11):e27285. PubMed ID: 22073305
[TBL] [Abstract][Full Text] [Related]
14. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
15. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
16. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
17. Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex.
Zhang Y; Chen Z; Wang F; Sun H; Zhu X; Ding J; Zhang T
Structure; 2022 Mar; 30(3):386-395.e5. PubMed ID: 34793709
[TBL] [Abstract][Full Text] [Related]
18. A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.
Kim HJ; Yoon HJ; Kim SY; Yoon YR
Mol Cells; 2014 Aug; 37(8):598-604. PubMed ID: 25134536
[TBL] [Abstract][Full Text] [Related]
19. LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis.
Lu D; Li J; Liu H; Foxa GE; Weaver K; Li J; Williams BO; Yang T
J Bone Miner Res; 2018 Oct; 33(10):1773-1784. PubMed ID: 29750835
[TBL] [Abstract][Full Text] [Related]
20. RARγ is a negative regulator of osteoclastogenesis.
Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]